Suppr超能文献

Sca1⁺小鼠垂体腺瘤细胞表现出肿瘤生长优势。

Sca1⁺ murine pituitary adenoma cells show tumor-growth advantage.

作者信息

Donangelo Ines, Ren Song-Guang, Eigler Tamar, Svendsen Clive, Melmed Shlomo

机构信息

Pituitary Center, Cedars-Sinai Medical Center, Regenerative Medicine Institute, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Los Angeles, California 90048, USA.

出版信息

Endocr Relat Cancer. 2014 Jan 30;21(2):203-16. doi: 10.1530/ERC-13-0229. Print 2014 Apr.

Abstract

The role of tumor stem cells in benign tumors such as pituitary adenomas remains unclear. In this study, we investigated whether the cells within pituitary adenomas that spontaneously develop in Rb+/- mice are hierarchically distributed with a subset being responsible for tumor growth. Cells derived directly from such tumors grew as spheres in serum-free culture medium supplemented with epidermal growth factor and basic fibroblast growth factor. Some cells within growing pituitary tumor spheres (PTS) expressed common stem cell markers (Sca1, Sox2, Nestin, and CD133), but were devoid of hormone-positive differentiated cells. Under subsequent differentiating conditions (matrigel-coated growth surface), PTS expressed all six pituitary hormones. We next searched for specific markers of the stem cell population and isolated a Sca1(+) cell population that showed increased sphere formation potential, lower mRNA hormone expression, higher expression of stem cell markers (Notch1, Sox2, and Nestin), and increased proliferation rates. When transplanted into non-obese diabetic-severe combined immunodeficiency gamma mice brains, Sca1(+) pituitary tumor cells exhibited higher rates of tumor formation (brain tumors observed in 11/11 (100%) vs 7/12 (54%) of mice transplanted with Sca1(+) and Sca1(-) cells respectively). Magnetic resonance imaging and histological analysis of brain tumors showed that tumors derived from Sca1(+) pituitary tumor cells were also larger and plurihormonal. Our findings show that Sca1(+) cells derived from benign pituitary tumors exhibit an undifferentiated expression profile and tumor-proliferative advantages, and we propose that they could represent putative pituitary tumor stem/progenitor cells.

摘要

肿瘤干细胞在垂体腺瘤等良性肿瘤中的作用仍不清楚。在本研究中,我们调查了Rb+/-小鼠自发形成的垂体腺瘤内的细胞是否呈分层分布,其中一部分细胞负责肿瘤生长。直接从这类肿瘤中获取的细胞在添加了表皮生长因子和碱性成纤维细胞生长因子的无血清培养基中呈球形生长。生长中的垂体肿瘤球(PTS)内的一些细胞表达常见的干细胞标志物(Sca1、Sox2、巢蛋白和CD133),但缺乏激素阳性分化细胞。在随后的分化条件下(基质胶包被的生长表面),PTS表达所有六种垂体激素。接下来,我们寻找干细胞群体的特异性标志物,并分离出一个Sca1(+)细胞群体,该群体表现出增加的成球潜力、较低的mRNA激素表达、较高的干细胞标志物(Notch1、Sox2和巢蛋白)表达以及增加的增殖率。当将其移植到非肥胖糖尿病-严重联合免疫缺陷γ小鼠脑内时,Sca1(+)垂体肿瘤细胞表现出更高的肿瘤形成率(分别移植Sca1(+)和Sca1(-)细胞的小鼠中,观察到脑肿瘤的比例为11/11(100%)对7/12(54%))。脑肿瘤的磁共振成像和组织学分析表明,源自Sca1(+)垂体肿瘤细胞的肿瘤也更大且为多激素性。我们的研究结果表明,源自良性垂体肿瘤的Sca1(+)细胞表现出未分化的表达谱和肿瘤增殖优势,我们认为它们可能代表假定的垂体肿瘤干/祖细胞。

相似文献

1
Sca1⁺ murine pituitary adenoma cells show tumor-growth advantage.
Endocr Relat Cancer. 2014 Jan 30;21(2):203-16. doi: 10.1530/ERC-13-0229. Print 2014 Apr.
2
Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas.
Mol Neurobiol. 2017 Sep;54(7):4879-4895. doi: 10.1007/s12035-016-0025-x. Epub 2016 Aug 11.
3
Evidence of brain tumor stem progenitor-like cells with low proliferative capacity in human benign pituitary adenoma.
Cancer Lett. 2014 Jul 10;349(1):61-6. doi: 10.1016/j.canlet.2014.03.031. Epub 2014 Apr 13.
4
[Isolation and preliminary identification of stem-like cells in pituitary adenoma].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2013 May;44(3):466-9.
5
Isolation of tumour stem-like cells from benign tumours.
Br J Cancer. 2009 Jul 21;101(2):303-11. doi: 10.1038/sj.bjc.6605142. Epub 2009 Jun 30.
7
The role of proto-oncogene GLI1 in pituitary adenoma formation and cell survival regulation.
Endocr Relat Cancer. 2015 Oct;22(5):793-803. doi: 10.1530/ERC-15-0109. Epub 2015 Jul 28.
9
Identification of CD133+ cells in pituitary adenomas.
Neuroendocrinology. 2011;94(4):302-12. doi: 10.1159/000330625. Epub 2011 Sep 8.
10
Pituitary progenitor cells tracked down by side population dissection.
Stem Cells. 2009 May;27(5):1182-95. doi: 10.1002/stem.51.

引用本文的文献

1
Update on Current Evidence for the Diagnosis and Management of Nonfunctioning Pituitary Neuroendocrine Tumors.
Endocrinol Metab (Seoul). 2023 Dec;38(6):631-654. doi: 10.3803/EnM.2023.1838. Epub 2023 Nov 15.
3
Primary Cultures from Human GH-secreting or Clinically Non-functioning Pituitary Adenomas.
Bio Protoc. 2018 Apr 5;8(7):e2790. doi: 10.21769/BioProtoc.2790.
4
Experimental Evidence and Clinical Implications of Pituitary Adenoma Stem Cells.
Front Endocrinol (Lausanne). 2020 Feb 20;11:54. doi: 10.3389/fendo.2020.00054. eCollection 2020.
5
Stem Cells in Pituitary Tumors: Experimental Evidence Supporting Their Existence and Their Role in Tumor Clinical Behavior.
Front Endocrinol (Lausanne). 2019 Oct 25;10:745. doi: 10.3389/fendo.2019.00745. eCollection 2019.
6
Pathogenesis of non-functioning pituitary adenomas.
Pituitary. 2018 Apr;21(2):130-137. doi: 10.1007/s11102-018-0874-6.
7
Stem/progenitor cells in pituitary organ homeostasis and tumourigenesis.
J Endocrinol. 2018 Jan;236(1):R1-R13. doi: 10.1530/JOE-17-0258. Epub 2017 Aug 30.
8
Expression and clinical significance of EGR-1 and PTEN in the pituitary tumors of elderly patients.
Oncol Lett. 2017 Aug;14(2):2165-2169. doi: 10.3892/ol.2017.6375. Epub 2017 Jun 13.
9
Expression of Stem Cell Markers and Dopamine D2 Receptors in Human and Rat Prolactinomas.
Med Sci Monit. 2017 Apr 15;23:1827-1833. doi: 10.12659/msm.901154.
10
The identification of human pituitary adenoma-initiating cells.
Acta Neuropathol Commun. 2016 Nov 28;4(1):125. doi: 10.1186/s40478-016-0394-4.

本文引用的文献

2
3
The adult pituitary shows stem/progenitor cell activation in response to injury and is capable of regeneration.
Endocrinology. 2012 Jul;153(7):3224-35. doi: 10.1210/en.2012-1152. Epub 2012 Apr 19.
4
Cancer stem cells: impact, heterogeneity, and uncertainty.
Cancer Cell. 2012 Mar 20;21(3):283-96. doi: 10.1016/j.ccr.2012.03.003.
5
EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas.
J Clin Invest. 2011 Dec;121(12):4712-21. doi: 10.1172/JCI60417. Epub 2011 Nov 21.
6
Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans.
Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11482-7. doi: 10.1073/pnas.1101553108. Epub 2011 Jun 2.
7
Stem cell sources for regenerative medicine: the immunological point of view.
Semin Immunopathol. 2011 Nov;33(6):519-24. doi: 10.1007/s00281-011-0271-y. Epub 2011 May 21.
8
Pituitary stem cell update and potential implications for treating hypopituitarism.
Endocr Rev. 2011 Aug;32(4):453-71. doi: 10.1210/er.2010-0011. Epub 2011 Apr 14.
9
Cells of origin in cancer.
Nature. 2011 Jan 20;469(7330):314-22. doi: 10.1038/nature09781.
10
Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.
Drug Resist Updat. 2010 Aug-Oct;13(4-5):109-18. doi: 10.1016/j.drup.2010.07.001. Epub 2010 Aug 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验